1. Home
  2. BGIN vs CERS Comparison

BGIN vs CERS Comparison

Compare BGIN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$3.34

Market Cap

343.9M

Sector

N/A

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.47

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGIN
CERS
Founded
2019
1991
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
343.9M
276.0M
IPO Year
2025
1997

Fundamental Metrics

Financial Performance
Metric
BGIN
CERS
Price
$3.34
$2.47
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
32.7K
1.6M
Earning Date
02-22-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$205,457,324.00
$199,191,000.00
Revenue This Year
N/A
$25.31
Revenue Next Year
N/A
$9.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.03
52 Week Low
$2.38
$1.12
52 Week High
$6.50
$2.96

Technical Indicators

Market Signals
Indicator
BGIN
CERS
Relative Strength Index (RSI) 53.87 58.68
Support Level $3.20 $2.44
Resistance Level $3.52 $2.74
Average True Range (ATR) 0.19 0.16
MACD 0.03 -0.00
Stochastic Oscillator 56.34 51.76

Price Performance

Historical Comparison
BGIN
CERS

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is operating through its subsidiaries and is engaged in digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies and a strategic focus on alternative cryptocurrencies. It design and sell mining machines equipped with proprietary 8nm or 12nm ASIC chips under different series dedicated to the mining of KAS coins, ALPH coins, and RXD coins. The Company operated in two reportable segments, which were the cryptocurrency mining and the sale of mining machines Key revenue is generated from Sale of mining machines. Geographically, It derives key revenue from Hong Kong, China and Vietnam, United States, Singapore, etc.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: